Literature DB >> 3016200

Methods for producing a reproducible crush in the sciatic and tibial nerve of the rat and rapid and precise testing of return of sensory function. Beneficial effects of melanocortins.

P De Koning, J H Brakkee, W H Gispen.   

Abstract

A procedure for placing a crush lesion in the sciatic and tibial nerve of the rat based on anatomical landmarks is described. These crush lesions are used to study the process of regeneration of peripheral nervous tissue and the beneficial effects of melanocortins on speed and quality of nerve regeneration. A new precise and rapid method for testing the return of sensory function by a locally applied electric stimulus is discussed.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3016200     DOI： 10.1016/0022-510x(86)90109-7

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN： 0022-510X            Impact factor:   3.181


  20 in total

1.  Treatment of diabetic polyneuropathy with the neurotrophic peptide ORG 2766.

Authors:  G D Valk; A C Kappelle; A M Tjon-A-Tsien; B Bravenboer; K Bakker; R P Michels; C M Groenhout; F W Bertelsmann
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

2.  Chronic nerve compression alters Schwann cell myelin architecture in a murine model.

Authors:  Ranjan Gupta; Nima Nassiri; Antony Hazel; Mary Bathen; Tahseen Mozaffar
Journal:  Muscle Nerve       Date:  2012-02       Impact factor: 3.217

3.  Putative neurotrophic factors and functional recovery from peripheral nerve damage in the rat.

Authors:  C E Van der Zee; J H Brakkee; W H Gispen
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

4.  The effect of MS-818, a pyrimidine compound, on the regeneration of peripheral nerve fibers of mice after a crush injury.

Authors:  X M Jiang; A Ohnishi; T Yamamoto; Y Murai; A Awaya; M Ikeda
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

5.  Randomized double-blind placebo-controlled trial to evaluate the effect of the ACTH4-9 analogue ORG 2766 in IDDM patients with neuropathy.

Authors:  B Bravenboer; P H Hendrikse; P L Oey; A C van Huffelen; C Groenhout; W H Gispen; D W Erkelens
Journal:  Diabetologia       Date:  1994-04       Impact factor: 10.122

Review 6.  Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.

Authors:  M Links; C Lewis
Journal:  Drugs       Date:  1999-03       Impact factor: 9.546

7.  Nasal administration of an ACTH(4-9) peptide analogue with dimethyl-beta-cyclodextrin as an absorption enhancer: pharmacokinetics and dynamics.

Authors:  N G Schipper; J C Verhoef; L M De Lannoy; S G Romeijn; J H Brakkee; V M Wiegant; W H Gispen; F W Merkus
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

8.  Insulin-like growth factor II stimulates motor nerve regeneration.

Authors:  S L Near; L R Whalen; J A Miller; D N Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

9.  Early Surgical Decompression Restores Neurovascular Blood Flow and Ischemic Parameters in an in Vivo Animal Model of Nerve Compression Injury.

Authors:  James Jung; Peter Hahn; Bernard Choi; Tahseen Mozaffar; Ranjan Gupta
Journal:  J Bone Joint Surg Am       Date:  2014-06-04       Impact factor: 5.284

10.  Estradiol promotes neural stem cell differentiation into endothelial lineage and angiogenesis in injured peripheral nerve.

Authors:  Haruki Sekiguchi; Masaaki Ii; Kentaro Jujo; Tina Thorne; Aiko Ito; Ekaterina Klyachko; Hiromichi Hamada; John A Kessler; Yasuhiko Tabata; Masatoshi Kawana; Michio Asahi; Nobuhisa Hagiwara; Douglas W Losordo
Journal:  Angiogenesis       Date:  2012-09-02       Impact factor: 9.596
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.